Relay Therapeutics, Inc. (RLAY)
12.45
+0.35
(+2.89%)
USD |
NASDAQ |
May 19, 14:46
Relay Therapeutics EPS Diluted (Quarterly) : -0.4075 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -0.6366 |
| Spyre Therapeutics, Inc. | -0.8785 |
| Revolution Medicines, Inc. | -2.291 |
| Tango Therapeutics, Inc. | -0.317 |
| Summit Therapeutics, Inc. | -0.2443 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -73.29M |
| Revenue (Quarterly) | 3.00M |
| Total Expenses (Quarterly) | 76.29M |
| Enterprise Value | 1.708B |
| Gross Profit Margin (Quarterly) | 83.20% |
| Profit Margin (Quarterly) | -2.44K% |
| Earnings Yield | -12.57% |
| Normalized Earnings Yield | -12.57 |